A Study to Explore the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JNJ-53718678 at Two Dose Levels in Non-Hospitalized Adult Participants Infected With Respiratory Syncytial Virus
Clinical trial NCT03379675 · COMPLETED
Trial details
- NCT number
- NCT03379675
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-06
- Primary completion
- 2019-11-27
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.